At a glance
ClinicalIndex Comparison RecordN/ACompleted· 508 enrolled
Drug / intervention
Fesoterodinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Post Marketing Surveillance To Assess The Safety And Efficacy Of Fesoterodine (Toviaz) On Filipino Patients Diagnosed With Over-Active Bladder
In Brief
An observational study evaluating Fesoterodine for Over Active Bladder. Completed, enrolled 508 participants across 37 sites.
Detailed Summary
This is an observational study and will determine the safety profile of fesoterodine in Filipino patients prescribed the drug. This is in compliance with the requirements of the Philippine Food and Drug Administration.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsOver Active Bladder
CountriesPhilippines
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedDec 2010
Enrollment StartFeb 2011
Primary CompletionOct 2013
TodayJul 2026
First PostedDec 15, 2010
Enrollment StartFeb 1, 2011
Primary CompletionOct 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 15.5 years ago
Interventions
Fesoterodinedrug
Any dose of Fesoterodine